William D Travis

15PUBLICATIONS
115CO-AUTHORS
Predictive and prognostic markersLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|May 25, 2026
Sex Impacts Progression-Free Survival of Alectinib through Drug Exposure in Patients with ALK-Positive Non-Small Cell Lung Cancer.

|Apr 08, 2026
Prospective clinical evaluation of cell-free DNA next generation sequencing in patients with suspected metastatic lung cancer.

Christi M J Steendam, Ruud W J Meijers, Peggy Atmodimedjo

|Jan 13, 2026
Adjuvant Durvalumab in Completely Resected Early-Stage Non-Small Cell Lung Cancer.

Glenwood D Goss, Gail E Darling, Virginie Westeel

|Nov 14, 2025
Actionable Genomic Alterations in Large Cell Neuroendocrine Carcinoma: A European Case Series of Patients Treated With a Small Molecule Inhibitor.

Frank W J Heijboer, Marta Brambilla, Mario Occhipinti

|May 27, 2025
Folinic Acid Prophylaxis and Dose Adjustments Enable Safe Treatment with Pemetrexed in Patients with Renal Impairment.

Nikki de Rouw, Leila-Sophie Otten, Mart P Kicken

|May 01, 2025
Semaglutide impairs bioavailability of alectinib: a note of warning based on a cross-over pharmacokinetic drug-drug interaction study.

Niels Heersche, Daan A C Lanser, Esther Oomen-de Hoop

Pageof 3

Frequent Collaborators

5 joint publications

Ron H J Mathijssen

4 joint publications

Hendrikus Jan Dubbink

3 joint publications

Ron H N van Schaik

2 joint publications

Melinda A Pruis